Psilocybin for stress disorders, post-traumatic

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 3 registered trials.

Why this status

  1. 1 Apr 2026: Trial started, NCT07703722
  2. 14 Jul 2026: Trial registered, NCT07703722

The trials

NCT06853912: PsiloStudy: Psilocybin With Psychological Support (Psi-PS) for Military Veterans and First Responders With Co-occurring PTSD & Alcohol Use Disorder (AUD)

State
Under way
Phase
Phase 2
People
40 planned
Started
1 Jun 2025
Primary completion
1 Nov 2026
Arms
Psilocybin + Nondirective Psychological Support
Results
None posted
  1. 3 Mar 2025: Trial registered
  2. 1 Jun 2025: Trial started

NCT06902974: Psilocybin-Assisted Therapy for Sexual Assault-Related PTSD

State
Under way
Phase
Phase 2
People
70 planned
Started
23 May 2026
Primary completion
Nov 2027
Arms
Psilocybin-Assisted Therapy
Results
None posted
  1. 30 Mar 2025: Trial registered
  2. 23 May 2026: Trial started

NCT07703722: Effect of Psilocybin and Structured Integrated Reframing Therapy on Gut-Brain Axis Biomarkers and Depression in Major Depressive Disorder

State
Under way
Phase
Phase 3
People
60 planned
Started
1 Apr 2026
Primary completion
22 Oct 2027
Arms
Psilocybin Therapy
Results
None posted
  1. 1 Apr 2026: Trial started
  2. 14 Jul 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Also known as High Dose Psilocybin, Low Dose Psilocybin, Medium Dose Psilocybin, Psilocybin (0.25mg/kg), Psilocybin (Usona Institute), Psilocybin (drug), Psilocybin 100 mcg/kg, Psilocybin 25 mg, Psilocybin 25 mg per os, Psilocybin 25mg, Psilocybin assisted therapy, Psilocybin first, Psilocybin plus Visual Healing Set and Setting, Psilocybin therapy, psilocybin 25 mg sod.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.